{"text_format":"2","workbook":"xls","n_sheets":1,"sheets":["report2"],"not_rendered":{"charts":0,"images":0,"macros":0,"external_links":1,"defined_names":1,"comments":0,"pivot_tables":0},"unopened":[],"bounds":{"document_bytes":16777216,"sheet_cells":100000,"run_cost":"one","rows_first":2000,"rows_last":500,"rows_between":2000,"halvings":0,"cell_chars":16384,"cell_head_chars":4096},"cells_cut":0,"cells_raw":0,"read":"whole","date_system":"1900","formulas":"cached_only"}

{"sheet":"report2","index":0,"n_rows":22,"n_cols":5,"rows_kept":22,"cut":false,"hidden":false,"merged":[[0,2,0,3],[0,4,0,5],[1,2,1,3],[1,4,1,5],[2,2,2,3],[2,4,2,5],[3,2,3,3],[4,2,4,3],[5,2,5,3],[6,2,6,3],[7,2,7,3],[9,2,9,3],[10,2,10,3],[14,2,14,3]],"flags":["formulas_cached_only"]}
[null,"1.","Record Nr.",null,"UNINA9910786951403321"]
[null,null,"Autore",null,"Benoit Michelle F"]
[null,null,"Titolo",null,"Gynecologic oncology handbook [[electronic resource] ] : an evidence-based clinical guide / / Michelle F. Benoit, Marian Yvette Williams-Brown, Creighton L. Edwards"]
[null,null,"Pubbl/distr/stampa",null,"New York, NY, : Demos Medical Publising, LLC, c2013"]
[null,null,"ISBN",null,"1-61705-167-5"]
[null,null,"Descrizione fisica",null,"1 online resource : illustrations"]
[null,null,"Disciplina",null,"616.99/465"]
[null,null,"Soggetti",null,"Generative organs, Female - Cancer"]
[{"$nulls":4},"Evidence-based medicine"]
[null,null,"Lingua di pubblicazione",null,"Inglese"]
[null,null,"Formato",null,"Materiale a stampa"]
[null,null,null,"Livello bibliografico","Monografia"]
[null,null,null,"Note generali","Description based upon print version of record."]
[null,null,null,"Nota di bibliografia","Includes bibliographical references and index."]
[null,null,"Nota di contenuto",null,"Cover; Title; Copyright; Contents; Preface; Chapter 1: Gynecologic Oncology Referral Parameters; I. Endometrial Cancer; II. Pelvic Mass; III. Cervical Cancer; IV. Vaginal Cancer; V. Vulvar Cancer; VI. Gestational Trophoblastic Disease; Chapter 2: Disease Sites; A: Preinvasive Disease; I. Cervical Intraepithelial Neoplasia (CIN); II. Vulvar Intraepithelial Neoplasia; III. Vaginal Intraepithelial Neoplasia (VAIN); IV. Dysplasia and HIV; References; B: Cervical Cancer; I. Characteristics; II. Pretreatment Workup; III. Histology; IV. Staging; V. Overall survival by stage; VI. Treatment"]
[{"$nulls":4},"VII. Surgical TreatmentVIII. Radiotherapy; IX. Adjuvant Posthysterectomy Treatment; X. Advanced Disease; XI. Recurrent Disease; XII. Survival; XIII. Prognostic Factors for Survival; XIV. Follow-Up; XV. Notable Trials in Cervical Cancer; References; C: Ovarian Cancer; I. General Characteristics; II. General Workup; III. General Treatment; IV. Histology; V. General Staging; Epithelial Ovarian Cancer; I. Characteristics; II. Workup; III. Histology; IV. Staging; V. Treatment; VI. Chemotherapy for Epithelial Ovarian Cancer; VII. Treatment by Stage; VIII. Second-look laparotomy; IX. Recurrence"]
[{"$nulls":4},"X. Secondary cytoreductionXI. Cerebellar degeneration; XII. Survival; XIII. Survival Care; XIV. Epithelial Ovarian Cancer Trials; Ovarian Tumors of Low Malignant Potential (LMP); I. Characteristics; II. Histology; III. Workup; IV. Staging; V. Treatment; VI. Recurrence; VII. Survival; VIII. Survival Care; Fallopian Tube Cancer; I. Characteristics; II. Workup; III. Histology; IV. Staging; V. Treatment; VI. Survival; VII. Survival care; Primary Peritoneal Cancer; Germ Cell Tumors (GCT); I. Characteristics; "]
[{"$nulls":4},"II. Workup; III. Staging; IV. Treatment; V. Recurrence; VI. Follow-Up"]
[{"$nulls":4},"VII. Histological Subtypes and Directed TherapiesVIII. Germ Cell Tumor Trials; IX. Chemotherapy Protocols for Ovarian GCT; Sex Cord Stromal Tumors; I. Characteristics; II. Workup; III. Staging; IV. Treatment; V. Histology; VI. 5 Y Survival; VII. Sex Cord Stromal Tumor Trials; References; D: Uterine Cancer; I. Characteristics; II. Prognostic factors; III. Pretreatment Workup; IV. Histology; V. Staging; VI. Grade is specified as a 3-tiered system; VII. Treatment; VIII. Recurrence; IX. Postoperative hormonal replacement therapy; X. Synchronous ovarian neoplasm; XI. Survival; XII. Follow-Up"]
[{"$nulls":4},"XIII. TamoxifenNotable Studies in Uterine Cancer; I. High-Risk Early-Stage Disease Adjuvant Therapy Studies; Uterine Sarcomas; I. Characteristics; V. Prognostic factors; VI. Follow-Up; References; E: Vulvar Cancer; I. Characteristics; II. Workup; III. Histology; IV. Staging; V. Treatment; VI. Recurrence; VII. Survival; VIII. Follow-up; Notable Studies; References; F: Vaginal Cancer; I. Characteristics; II. Pretreatment Workup; III. Histology; IV. Staging; V. Treatment; VI. Recurrent Disease; VII. Survival; VIII. Follow-up; G: Gestational Trophoblastic Disease; I. Characteristics"]
[{"$nulls":4},"II. Histology"]
[null,null,null,"Sommario/riassunto","Gynecologic Oncology Rotation Quick Reference provides a comprehensive yet concise, practical guide for fellows, residents, and specialist trainees in the diagnosis and management of gynecologic cancers. The book addresses the fundamentals of gynecologic oncology, including staging, surgical technique, comorbidity diagnosis and management, adjuvant therapies including chemotherapy and radiation, and survival and palliative care. The focus is on specific management decision-making and the book provides the basic information needed to guide the clinician on the ward or in the clinic including cl"]